2-Acetyl-5-methylpyrazine
Common Name: |
2-Acetyl-5-methylpyrazine |
IUPAC Name: |
1-(5-methylpyrazin-2-yl)ethanone |
Molecular Formula: |
C14H18O |
SMILES: |
CC1=CN=C(C=N1)C(=O)C |
Inchi: |
1S/C7H8N2O/c1-5-3-9-7(4-8-5)6(2)10/h3-4H,1-2H3 |
Inchi Key: |
LPQFLJXNMCVMCO-UHFFFAOYSA-N |
Cas No: |
22047-27-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
202.29 |
Mass (g/mol) |
136.064 |
Molar Refractivity |
65.58 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
6 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
3 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
56 |
Boiling Point (°C@760.00mm Hg) |
226.00 to 228.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.07 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.36 |
LogP |
0.988 |
iLOGP |
2.76 |
XLOGP3 |
4.24 |
WLOGP |
3.74 |
MLOGP |
3.42 |
ESOL Log S |
-3.67 |
ESOL Solubility (mg/ml) |
0.044 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.31 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-4.45 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.52 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.388 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.044 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |